HAMF
GWPH

Hatteras Alternative Mutual Funds’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Hatteras Alternative Mutual Funds’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-6,000
Closed -$249K – 174
2013
Q4 		$249K Buy
+6,000
New +$190K 0.14% 152

Other funds holding GWPH

PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hatteras Alternative Mutual Funds's GWPH Position: Q1 2014 in Review

Hatteras Alternative Mutual Funds sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2014, closing a stake of 6,000 shares — an estimated $249K sold.

Hatteras Alternative Mutual Funds first reported a position in GWPH in Q4 2013 and held it in 1 quarter. The position peaked at $249K in Q4 2013. 68 funds tracked by Wall St. Rank hold GWPH as of Q1 2014.

  • Hatteras Alternative Mutual Funds reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2014 after selling out during the quarter.
  • Hatteras Alternative Mutual Funds sold 6,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2014, an estimated $249K.
  • Hatteras Alternative Mutual Funds first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 1 quarter.
  • Hatteras Alternative Mutual Funds's GW Pharmaceuticals Plc American Depositary Shares position peaked at $249K in Q4 2013.
  • 68 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2014.

Based on Hatteras Alternative Mutual Funds's 13F filing for Q1 2014, filed 9 May 2014.